Abiopharma

News list

Director Schellhase David 🟡 adjusted position in 0 shares (1 derivative) of Okta, Inc. (OKTA) Transaction Date: Aug 13, 2026 | Filing ID: 000004

Full text

News bot Aug. 17, 2026, 10:02 p.m.
🔍 Schellhase David (Director)

Company: Okta, Inc. (OKTA)

Report Date: 2026-08-13
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,942
- Total shares sold: 1,942
Detailed Transactions and Holdings:
- Acquired 1,942 shares of Class A Common Stock (Direct)
  Date: 2026-08-13 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,654.00 | transaction_form_type: 4
- Sold 1,942 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-13 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,884.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Class A Common Stock.
- F2: 33-1/3% of the shares underlying the RSU vested on August 13, 2026, and the remaining shares underlying the RSU shall vest in 2 equal annual installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such date.